June 12 (Reuters) - BIONTECH SE:

* BIONTECH ANNOUNCES STRATEGIC TRANSACTION TO ACQUIRE

CUREVAC IN

PUBLIC EXCHANGE OFFER

* PUBLIC EXCHANGE OFFER FOR ALL SHARES OF CUREVAC WHERE EACH

SHARE

OF CUREVAC WILL BE EXCHANGED FOR APPROX. $5.46 IN BIONTECH

AMERICAN DEPOSITARY SHARES

* IMPLIED AGGREGATE EQUITY VALUE FOR CUREVAC OF APPROX.

$1.25

BILLION

* EXPECTED TO CLOSE IN 2025

* TRANSACTION WAS UNANIMOUSLY APPROVED BY BOTH BIONTECH'S

AND

CUREVAC'S MANAGEMENT AND SUPERVISORY BOARDS

* CUREVAC SHAREHOLDERS TO OWN 4%-6% OF BIONTECH POST-DEAL

* SHAREHOLDERS REPRESENTING 36.76% OF CUREVAC SHARES ENTER

TENDER

AGREEMENTS

Source text:

Further company coverage:

(Gdansk Newsroom)